Delays in securing regulatory approvals in the United States and Australia as well as slower than expected product sales have prompted Clinical Cell Culture Ltd to announce staff cuts and postponement of some R&D.
15/03/2006 - 11:24
C3 to cut staff numbers and postpone R&D
15/03/2006 - 11:24
